April 15th, 2025
GC Therapeutics Pioneers Cell Therapy at Warp Speed
With funding and business development support from the Blavatnik Biomedical Accelerator, a research team’s lab discovery propelled to startup success.
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Hms
April 15th, 2025
With funding and business development support from the Blavatnik Biomedical Accelerator, a research team’s lab discovery propelled to startup success.
February 7th, 2025
The team that performed first-of-its-kind surgery in 2024 has successfully transplanted another genetically edited pig kidney into a living person.
January 24th, 2025
Scientists zoom in on microbial messages at the molecular level to understand how the microbiome shapes health.
September 19th, 2024
GC Therapeutics (GCTx), a Harvard startup, announced its launch to scale and its technology TFome™, the world’s first “plug and play” induced pluripotent stem cell (iPSC) programming platform for cell therapies in multiple therapeutic areas.
April 17th, 2024
Startup launches based on a Harvard discovery to address the global plastics crisis.